Girish Mahajan (Editor)

Amphastar Pharmaceuticals

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Amphastar Pharmaceuticals patentdocstypepadcoma6a00d83451ca1469e2017744

Traded as
  
NASDAQ: AMPHS&P 600 Component

Stock price
  
AMPH (NASDAQ) US$ 15.47 -0.25 (-1.59%)28 Feb, 4:00 PM GMT-5 - Disclaimer

Headquarters
  

14 56382 amphastar pharmaceuticals inc v aventis pharma sa


Amphastar Pharmaceuticals is a publicly traded American pharmaceutical company. Its products include Enoxaparin Sodium Injection, Cortrosyn, Amphadase, Emergency Syringes in Luer-Jet, Lidocaine, Naloxone, and Phytonadione Injection.

Contents

Controversies

Amphastar has been criticized for its pricing of naloxone, a drug that treats opiod overdose.

References

Amphastar Pharmaceuticals Wikipedia


Similar Topics